Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
π° News Media
- π§ [National] Elon Muskβs Inner Circle Is Pouring Cash Into Making Psychedelics Mainstream - wsj.com
- π° [National] Runaway Drug Violence Sets Off a Political Earthquake in Costa Rica - wsj.com
- π₯ [Vermont] Vermont teen mental health improves as vaping rates drop, study finds - vnews.com
π£οΈ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- π€ Medication safety pearls from ASHP 2025: AI event review, ER naloxone kits and fewer pharmacy stickers to reduce errors. (link) - @PharmPracNews on X
- π§ͺ no one has to die. learn more about what to do if you see someone potentially OD'ing and with your cert access free naloxone and fent test strips π«‘ (link) - @angelbabyhze on X
Opposition Views
π City Updates
- No recent City Updates found.
π Academic Research
- π Co-treating Opioid and Alcohol Use Disorders in the United States, 1960-2026: A Historical Policy Review in the Glucagon-Like Peptide-1 (GLP-1) Era - Drug and Alcohol Dependence Reports - 2026-09-01 - doi.org
- π Successful Management Of Refractory Precipitated Opioid Withdrawal Syndrome Following Buprenorphine Intake Using Ketamine: A Case Report - 2026-09-03 - doi.org
- π» A Measurement-Based Care Strategy for Buprenorphine-Naloxone Treatment (Bup-MBC): Development of an EHR-Integrated Intervention - 2026-09-01 - doi.org
βοΈ Law & Policy
- No hits in Law and Policy today.
πΈ Funding
Current
- Deadline Approachingπ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- π¬ National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- π¬ National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- π¬ National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- π¬ National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- π¬ National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- π₯ Hearst Foundations - Health - Hearst Foundations Health β Year-round, rolling grant applications (non-endowment) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π₯ Hearst Foundations - Social Service - Hearst Foundations β Social Service (year-round, rolling applications via Grants Portal) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π€ Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch